Top Markets
#1 QuantixAI QuantixAI +63.61%
#2 GEKKO GEKKO +43.09%
#3 Versatize Coin Versatize Coin +39.99%
#4 UnifAI Network UnifAI Network +29.42%
#5 MowCat MowCat +29.40%
#6 Storj Storj +29.08%
#7 Pons Pons +28.88%
#8 Prom Prom +28.67%
#9 Kinesis Silver Kinesis Silver +23.94%
#10 Fake World Assets Fake World Assets +22.62%
Coin of the day
QuantixAI QuantixAI
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Vaxart, Inc. Vaxart, Inc.

Vaxart, Inc.

VXRT
Peringkat dalam Saham #20724
Vaxart, Inc. operates as a biotechnology firm currently in the clinical... Vaxart, Inc. operates as a biotechnology firm currently in the clinical development phase, concentrating its efforts on identifying and advancing novel oral recombinant protein vaccines. The company leverages its unique proprietary platform for delivering these oral vaccine solutions. Its diverse pipeline showcases several promising candidates: An oral tablet vaccine targeting norovirus, which is presently undergoing Phase Ib clinical assessment for both GI.1 and GII.4 strains. A seasonal influenza vaccine, now in Phase II clinical studies, designed to address H1 influenza infections. A vaccine candidate against respiratory syncytial virus (RSV). A coronavirus vaccine, also advancing through Phase II clinical trials for SARS-CoV-2. Beyond infectious diseases, Vaxart is also engaged in formulating therapeutic vaccines aimed at treating cervical cancer and dysplasia associated with human papillomavirus. The company's main operations are situated in South San Francisco, California.
Harga Saham
$0.5106
Kapitalisasi Pasar
$123.59M
Perubahan (1 hari)
-1.81%
Perubahan (1 tahun)
45.89%
Negara
US
Perdagangan Vaxart, Inc. (VXRT)

Kategori

Healthcare
Laba untuk Vaxart, Inc. (VXRT)
Laba pada 2026 TTM: 0
Menurut laporan keuangan terbaru dari Vaxart, Inc., laba saat ini perusahaan adalah 0. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Vaxart, Inc. dari 2026 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH